Back to search
FDAFDA · Food and drugs·Recall number D-297-2013

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.

Published May 1, 2013 · Recall initiated: April 8, 2013

Summary

FDA records drug Class II recall D-297-2013, published May 1, 2013 and initiated April 8, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 245,250 vials; Lot: Lot #: 11-185-DJ*, 11-196-DJ*, Exp 1NOV2013; * may be followed by 01 or 02. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: A single visible particulate was identified during a retain sample inspection.

What to do

Voluntary: Firm initiated · Letter

Get an email if PROPOFOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PROPOFOL
Manufacturer
Hospira Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 11-185-DJ*, 11-196-DJ*, Exp 1NOV2013; * may be followed by 01 or 02
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30. recalled?

Yes. FDA published recall D-297-2013 on May 1, 2013. Reported hazard: Presence of Particulate Matter: A single visible particulate was identified during a retain sample inspection.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PROPOFOL.